RN7SL332P

Across TCGA pan-cancer cohorts, RN7SL332P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL332P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL332P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL332P expression acts as an unfavorable survival marker.

MESO, THYM, and ESCA are the cancer types where RN7SL332P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.071	0.572	<.001	72	view →
THYM	OS	Tertile	All	0.549	0.974	<.001	45	view →
ESCA	OS	Tertile	All	0.489	0.721	.002	33	view →
LUAD	DFS	Tertile	II,III,IV	0.283	0.660	.006	27	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	27	view →
BRCA	DFS	Tertile	III,IV	0.193	0.500	.009	24	view →
BLCA	DFS	Tertile	IV	0.111	0.479	.002	21	view →
PAAD	DFS	Tertile	All	0.232	0.490	.014	18	view →
SKCM	OS	Tertile	III,IV	0.491	0.807	.029	9	view →
LIHC	OS	Tertile	III,IV	0.117	0.535	.020	9	view →
LGG	OS	Tertile	All	0.234	0.468	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL332P–MESO (OS)

Open the MESO breakdown →